To investigate the regulatory role of TRIM37 in sunitinib resistance, we conducted experiments involving the modulation of TRIM37 expression in RCC cells and the administration of appropriate concentrations of DMSO and sunitinib. Here, TRIM37 is linked to renal cell carcinoma.